95389 ⎘
Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both Sulfur atom
Sub-classes:METHOD FOR PRODUCING ARYL COMPOUND CONTAINING TRITYLSULFANYL GROUP
#2INHIBITORS OF NITRIC OXIDE SYNTHASES (NOS), PHARMACEUTICAL PRODUCTS THEREOF, AND METHODS THEREOF
#3TYK2 inhibitors and uses thereof
#4Preparation and use of kinase inhibitor
#5TYK2 inhibitors and uses thereof
#6Preparation and use of kinase inhibitor
#7Purine derivatives as CD73 inhibitors for the treatment of cancer
#8Thionating agent
#9Thionation process and a thionating agent
#10Quinoxaline and quinoline derivatives as kinase inhibitors
#11Cyclopropyl pyrrolidine orexin receptor antagonists
#12Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes
#13Purine Compunds as HSP90 Protein Inhibitors for the Treatment of Cancer
#14Condensed imidazole derivatives
#15Biologically active aphrocallistin compounds
#16Purine compounds
#17Purine derivatives as purinergic receptor antagonists
#18Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
#19Novel condensed imidazole derivatives
#20Condensed imidazole derivatives
#21Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
#22Phenyl substituted imidaopyridines and phenyl substituted benzimidazoles